Our data demonstrated that MT-ATP6/8 defects present as a metabolic encephalomyopathy in early-onset patients, with 56% of infantile patients with MT-ATPase deficiency and 48% of pediatric patients with MT-ATPase deficiency experiencing episodes of metabolic acidosis. The gene discussed is MCAT; the disease is metabolic acidosis.